Frontiers in Pharmacology | Pharmacogenetics and Pharmacogenomics

Systematic Review

Published on 21 Nov 2025

Impact of CYP2C19 point-of-care testing on the clinical outcome in patients receiving personalized clopidogrel therapy: systemic review and meta-analysis

in Pharmacogenetics and Pharmacogenomics

Shaban Mohammed
Zainab Ali
Nermin Mohammed
Ayman El-Menyar
Jassim Al Suwaidi
Moza Al-Hail
Wadha Al-Muftah
Rania Abdel-Latif
Maw Shin Sim

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1621327

282 views

Original Research

Published on 21 Nov 2025

Assessing the views and opinions of psychiatric patients receiving genome-guided treatment within the scope of the PREPARE preemptive pharmacogenomics clinical study

in Pharmacogenetics and Pharmacogenomics

Margarita-Ioanna Koufaki
Maria-Theodora Pandi
Maria Skokou
Kariofyllis Karamperis
Konstantinos Vasileiou
Christina Mitropoulou
Marc S. Williams
George P. Patrinos

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1722339

118 views

Original Research

Published on 19 Nov 2025

Pharmacogenetic associations of CYP2D6 and CYP2C19 variants with anticholinergic drug burden and hyposalivation

in Pharmacogenetics and Pharmacogenomics

Olga A. Korczeniewska
Scott Diehl
Abdul Basir Barmak
Tong Tong Wu
Eli Eliav
Szilvia Arany

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1713345

237 views

Mini Review

Published on 13 Nov 2025

Inhibition of mesenchymal drift as a strategy for rejuvenation

in Pharmacogenetics and Pharmacogenomics

Lucas Paulo de Lima Camillo

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1715559

396 views

Methods

Accepted on 30 Oct 2025

StarTRAC-CYP2D6: a method for CYP2D6 allele-specific copy number determination using digital PCR

in Pharmacogenetics and Pharmacogenomics

Wendy Y Wang
Erin C Boone
Lancy Lin
David J Joun
Andrea Gaedigk

Frontiers in Pharmacology

221 views

Original Research

Published on 30 Oct 2025

Persistent benefit of pharmacogenomic testing on initial remission and response rates in patients with major depressive disorder

in Pharmacogenetics and Pharmacogenomics

Daniel Hain
Andria L. Del Tredici
Ryan B. Griggs
Rebecca Law
Brent Mabey
Holly L. Johnson
Katherine Johansen Taber
Kevin G. Lynch
Alexander Gutin
David W. Oslin

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1658616

1,638 views

Review

Published on 30 Oct 2025

Epigenetic pharmacology in aging: from mechanisms to therapies for age-related disorders

in Pharmacogenetics and Pharmacogenomics

Haikuan Yu
Taojin Feng
Chengcheng Zhang
Zhouguang Jiao
Wenkai Fan
Rongxian Jiang
Dewen Kong
Fubing Li

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1699296

1,292 views

Original Research

Accepted on 22 Oct 2025

"Pharmacogenetic Variations and Clinical Implications of Actionable CYP2D6/CYP2C19 Variants in Central Indian Patients with Common Mental Disorders"

in Pharmacogenetics and Pharmacogenomics

SANTENNA CHENCHULA
Atal Shubham
Rozatkar Abhijit
Tamonud Modak
Kohat Komal
Ratinder Jhaj
Singh Jitendra
Satyaprakash V
Sadasivam Balakrishnan

Frontiers in Pharmacology

422 views

Original Research

Accepted on 09 Oct 2025

Effectiveness of Treatments to Prevent Femoral Periprosthetic Bone Loss in People Following Total Hip Arthroplasty: A Network Meta-analysis

in Pharmacogenetics and Pharmacogenomics

Zhihu Zhao
Tao Ling
Zhihu Zhao
Wei Luo
Jian-Xiong Ma
Xinlong Ma

Frontiers in Pharmacology

241 views

Original Research

Published on 09 Oct 2025

Patient and clinician perspectives on pharmacogenetic testing for antipsychotics

in Pharmacogenetics and Pharmacogenomics

Maria Richards-Brown
Yiran Wei
Rosemary Abidoph
Lauren Varney
Marius Cotic
Stephen Murtough
Daniele Panconesi
Daisy Mills
Alvin Richards-Belle
Noushin Saadullah Khani

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1689300

2,252 views

Original Research

Published on 08 Oct 2025

A digital twin of glimepiride for personalized and stratified diabetes treatment

in Pharmacogenetics and Pharmacogenomics

Michelle Elias
Matthias König

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1686415

1,361 views

Original Research

Published on 02 Oct 2025

Genetic and serum biomarkers of NSAID hypersensitivity reactions

in Pharmacogenetics and Pharmacogenomics

G. Amo
J. M. García-Menaya
M. Martí
J. Gómez-Tabales
J. A. Cornejo-García
N. Blanca-López
G. Canto
I. Doña
M. Blanca
M. J. Torres

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1502755

2,035 views

Review

Published on 01 Oct 2025

Pharmacogenomics of antibiotic-induced hypersensitivity reactions: current evidence and implications in clinical practice

in Pharmacogenetics and Pharmacogenomics

Mohitosh Biswas
Murshadul Alam Murad
Md. Ismail Hossain Ashik
Maliheh Ershadian
Chonlaphat Sukasem

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1651909

2,558 views

Original Research

Published on 25 Sep 2025

Pharmacogenomic biomarkers of ACE inhibitor–induced cough in a multi-ethnic UAE cohort

in Pharmacogenetics and Pharmacogenomics

Sahar M. Altoum
Zeina N. Al-Mahayri
Lubna Q. Khasawneh
Mais N. Alqasrawi
Lilas Dabaghie
Dana Hamza
Bassam R. Ali

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1655617

2,001 views

Systematic Review

Published on 22 Sep 2025

Implementing pharmacogenetic testing in community pharmacy practice: a scoping review

in Pharmacogenetics and Pharmacogenomics

Aude Coumau
Claire Coumau
Chantal Csajka

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1659875

3,197 views

Review

Published on 19 Sep 2025

Advancing drug safety in psychiatry: insights from pharmacogenomics of hypersensitivity reactions

in Pharmacogenetics and Pharmacogenomics

Hamid A. Alhaj
Jana Samara
Alyamama Alnamous
Rama Karima
Maha Saber-Ayad

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1651898

3,658 views